286 related articles for article (PubMed ID: 32441411)
21. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.
Zouboulis CC; Tzellos T; Kyrgidis A; Jemec GBE; Bechara FG; Giamarellos-Bourboulis EJ; Ingram JR; Kanni T; Karagiannidis I; Martorell A; Matusiak Ł; Pinter A; Prens EP; Presser D; Schneider-Burrus S; von Stebut E; Szepietowski JC; van der Zee HH; Wilden SM; Sabat R;
Br J Dermatol; 2017 Nov; 177(5):1401-1409. PubMed ID: 28636793
[TBL] [Abstract][Full Text] [Related]
23. Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity.
Schrader AM; Deckers IE; van der Zee HH; Boer J; Prens EP
J Am Acad Dermatol; 2014 Sep; 71(3):460-7. PubMed ID: 24880664
[TBL] [Abstract][Full Text] [Related]
24. HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa.
Peris K; Lo Schiavo A; Fabbrocini G; Dini V; Patrizi A; Fusano M; Bianchi L; Guanziroli E; Guarneri C; Parodi A; Bertoldi A; Musumeci ML; Offidani A; Rongioletti F; Pistone G; Malara G; Potenza C; Casari A; Franchi C; Ardigò M; Cusano F; Stingeni L; Amerio P; Mancini LL; Prignano F; Deboli T; Gualberti G; Saragaglia V; Bettoli V
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):766-773. PubMed ID: 30633405
[TBL] [Abstract][Full Text] [Related]
25. Epicardial fat thickness is ıncreased and associated with disease severity in hidradenitis suppurativa.
Alatas ET; Biteker M; Alatas OD
Arch Dermatol Res; 2020 Sep; 312(7):467-472. PubMed ID: 31894390
[TBL] [Abstract][Full Text] [Related]
26. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
[TBL] [Abstract][Full Text] [Related]
27. Characterization of comorbid conditions burdening hidradenitis suppurativa: a multicentric observational study.
Chiricozzi A; Giovanardi G; Caposiena Caro DR; Iannone M; De Simone C; Cannizzaro MV; Oranges T; Fossati B; Di Matteo E; Dini V; Bianchi L; Peris K
G Ital Dermatol Venereol; 2020 Jun; 155(3):335-340. PubMed ID: 30295448
[TBL] [Abstract][Full Text] [Related]
28. Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?
Krajewski PK; Marrón SE; Tomas Aragones L; Gilaberte-Calzada Y; Szepietowski JC
Dermatol Ther (Heidelb); 2022 Apr; 12(4):899-909. PubMed ID: 35274220
[TBL] [Abstract][Full Text] [Related]
29. Serum levels of serum amyloid A, interleukin-6 and C-reactive protein correlate with severity of hidradenitis suppurativa.
Srour J; Marsela E; Fiocco Z; Kendziora B; Gürtler A; French LE; Reinholz M
Ital J Dermatol Venerol; 2023 Aug; 158(4):341-346. PubMed ID: 37404192
[TBL] [Abstract][Full Text] [Related]
30. [Clinical evaluation of the severity of hidradenitis suppurativa].
Revuz J
Ann Dermatol Venereol; 2015 Dec; 142(12):729-35. PubMed ID: 26372547
[TBL] [Abstract][Full Text] [Related]
31. AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa.
Chiricozzi A; Faleri S; Franceschini C; Caro RD; Chimenti S; Bianchi L
Wounds; 2015 Oct; 27(10):258-64. PubMed ID: 26479209
[TBL] [Abstract][Full Text] [Related]
32. Haptoglobin is an independent marker for disease severity and risk for metabolic complications in hidradenitis suppurativa: A prospective study.
Abu Rached N; Gambichler T; Ocker L; Skrygan M; Seifert C; Scheel CH; Stockfleth E; Bechara FG
J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):205-213. PubMed ID: 37669834
[TBL] [Abstract][Full Text] [Related]
33. Thyroid Disease and Active Smoking May Be Associated with More Severe Hidradenitis Suppurativa: Data from a Prospective Cross Sectional Single-Center Study.
Liakou AI; Kontochristopoulos G; Marnelakis I; Tsantes AG; Papadakis M; Alevizou A; Rotsiamis N; Rigopoulos D
Dermatology; 2021; 237(1):125-130. PubMed ID: 32966979
[TBL] [Abstract][Full Text] [Related]
34. Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice.
Prens EP; Lugo-Somolinos AM; Paller AS; Kerdel F; Duan Y; Teixeira HD; Longcore M; Kimball AB
Am J Clin Dermatol; 2020 Aug; 21(4):579-590. PubMed ID: 32077014
[TBL] [Abstract][Full Text] [Related]
35. Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts.
Condamina M; Penso L; Tran VT; Hotz C; Guillem P; Villani AP; Perrot P; Bru MF; Jacquet E; Nassif A; Bachelez H; Wolkenstein P; Beylot-Barry M; Richard MA; Ravaud P; Viguier M; Sbidian E
Dermatology; 2021; 237(5):748-758. PubMed ID: 33503635
[TBL] [Abstract][Full Text] [Related]
36. Hidradenitis suppurativa epidemiology: from the first Italian registry in 2009 to the most recent epidemiology updates - Italian Registry Hidradenitis Suppurativa project 2.
Bettoli V; Cazzaniga S; Scuderi V; Zedde P; Di Landro A; Naldi L;
J Eur Acad Dermatol Venereol; 2019 Oct; 33 Suppl 6():4-6. PubMed ID: 31535758
[TBL] [Abstract][Full Text] [Related]
37. A retrospective study of the characteristics of patients with early-onset compared to adult-onset hidradenitis suppurativa.
Dessinioti C; Tzanetakou V; Zisimou C; Kontochristopoulos G; Antoniou C
Int J Dermatol; 2018 Jun; 57(6):687-691. PubMed ID: 29604044
[TBL] [Abstract][Full Text] [Related]
38. Twenty-four-week interim analysis from a phase 3 open-label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa.
Morita A; Takahashi H; Ozawa K; Imafuku S; Nakama T; Takahashi K; Matsuyama T; Okubo Y; Kitamura S; Matsuda N; Zhao Y; Yokoyama M; Hayashi N; Terui T
J Dermatol; 2019 Sep; 46(9):745-751. PubMed ID: 31282051
[TBL] [Abstract][Full Text] [Related]
39. Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS).
Hessam S; Sand M; Gambichler T; Bechara FG
J Am Acad Dermatol; 2015 Dec; 73(6):998-1005. PubMed ID: 26410359
[TBL] [Abstract][Full Text] [Related]
40. Descriptive Epidemiology of Hidradenitis Suppurativa in Greece: A Study of 152 Cases.
Katoulis AC; Liakou AI; Rotsiamis N; Bonovas S; Bozi E; Rallis E; Christodoulou C; Rigopoulos D
Skin Appendage Disord; 2017 Oct; 3(4):197-201. PubMed ID: 29177148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
